Subscribe to our Email Alerts

Island Pharmaceuticals
  • About Us
    • Island at a glance
    • Board
    • Key Management
    • Scientific Advisory Board
    • Collaborations
  • Science
    • About ISLA-101
    • Scientific Publications
    • Drug repurposing and benefits
    • Disease and drug terms explained
  • Investor Centre
    • Investor Welcome
      • Clinical programme
    • ASX Announcements
    • Presentations
    • Prospectus
    • Financial Reports
    • Share Price Information
    • Shareholder Services
    • Investor Fact Sheet
    • Corporate Governance
    • Corporate Directory
    • International Investors
    • Research Coverage
    • AGM
  • Media
    • News
    • IslandWatch Newsletter
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Media
Media > News
  • News
  • IslandWatch Newsletter

News

Filter by Year:2025 2024 2023 2022 2021 2020 
2-Dec-2024
Ausbiz: Island Pharma progressing in its fight against dengue
30-Nov-2024
BIOSHARES: Island Pharmaceuticals Achieves Endpoints in Phase 2a Study in Dengue Fever
28-Nov-2024
Webinar recording: Island Phase 2a readout investor briefing
27-Nov-2024
Webinar: Island CEO on major milestone of ISLA-101 Phase 2a trial in dengue
27-Nov-2024
The Australian: Island Pharmaceuticals Trial success with dengue fever drug
27-Nov-2024
Webinar recording: Island Phase 2a readout investor briefing and Q&A
6-Nov-2024
The Australian: Island Pharmaceuticals’ two-pronged plan to put the mozz on dengue fever
15-Oct-2024
The Australian: Pitt Street Research says Island Pharmaceuticals should be worth up to 115% more
15-Oct-2024
Bioshares: Island Pharmaceuticals Shares Surge on Trial Start and Capital Raise
8-Oct-2024
Island Pharmaceuticals Investor Update - October 2024
  • 1
  • 2
  • 3
  • 4
  •  Next

NOTICE

It has come to the company's attention that unauthorised individuals may be falsely claiming to represent Island Pharmaceuticals Limited in employment offers and recruitment communications. Please be advised that all legitimate employment opportunities are advertised through official company channels, the company's social media channels and via authorised recruitment partners.

Island Pharmaceuticals Limited will never request payment, personal financial information, or conduct interviews via unofficial platforms. If you receive a suspicious message or offer, please report it to us immediately at henry.jordan@sdir.com.au

Your safety and security are important to us.

Kind regards,
Island Pharmaceuticals Limited

Quick Links

Contact Us

Island Pharmaceuticals
Suite 201, 697 Burke Road
Camberwell, Victoria 3124

info@islandpharmaceuticals.com

www.islandpharmaceuticals.com

Email Alerts

Which of the following group do you best fit?

 

Follow Us

Follow Us

Site Map Privacy Search
Copyright © Island Pharmaceuticals
Site Map Privacy Search
Site by